CLINICAL TRIALS PROFILE FOR CARISOPRODOL
✉ Email this page to a colleague
All Clinical Trials for carisoprodol
| Trial ID | Title | Status | Sponsor | Phase | Start Date | Summary |
|---|---|---|---|---|---|---|
| NCT00671502 ↗ | A Study to Evaluate Two Formulations of Carisoprodol in Subjects With Musculoskeletal Spasm of the Lower Back | Completed | Meda Pharmaceuticals | Phase 3 | 2008-04-01 | The purpose of this study is to determine if two sustained released formulations of carisoprodol are more effective than placebo. |
| NCT00671879 ↗ | Study to Evaluate Two Formulations of Carisoprodol in Subjects With Musculoskeletal Spasm of the Lower Back | Completed | Meda Pharmaceuticals | Phase 3 | 2008-04-01 | The purpose of this study is to determine if two sustained released formulations of carisoprodol are more effective than placebo. |
| NCT01421433 ↗ | A Comparative Study Between Lysine Clonixinate+Cyclobenzaprine and Caffeine+Carisoprodol+Sodium Diclofenac+Paracetamol | Unknown status | Pharmagenix Projetos em Medicina Farmacêutica Ltda. | Phase 3 | 2012-05-01 | Non inferiority, multicentric, double blind study whose the primary objective is to compare the effectiveness of two products in pain reduction. Primary endpoint: reduction in pain average at day 7 compared to day 1(baseline), using Analogue Visual Scale (AVS) for pain evaluation. Secondary endpoint: to evaluate the products safety at the gastrointestinal system. |
| >Trial ID | >Title | >Status | >Sponsor | >Phase | >Start Date | >Summary |
Clinical Trial Conditions for carisoprodol
Condition Name
Clinical Trial Locations for carisoprodol
Trials by Country
Clinical Trial Progress for carisoprodol
Clinical Trial Phase
Clinical Trial Sponsors for carisoprodol
Sponsor Name
